Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on June 21, 2019, 11:43:57 am

Title: Mavyret Is Effective Among Those With Substance Abuse History
Post by: Hep Editors on June 21, 2019, 11:43:57 am

AbbVie’s Mavyret (glecaprevir/pibrentasvir) cures hepatitis C virus (HCV) at a high rate among individuals typically excluded from clinical trials, including those receiving medication-assisted treatment (MAT) for opioid use disorder, those abusing alcohol or drugs and those with psychiatric conditions.

Presenting their findings at the 53rd International Liver Congress in Vienna, researchers analyzed data on 1,698 people with genotypes 1 through 6 of HCV who received Mavyret treatment and were members of the German Hepatitis C-Registry.

For more...
https://www.hepmag.com/article/mavyret-effective-among-substance-abuse-history